本文已被:浏览 459次 下载 532次 |
![本文二维码信息](/download_upload_file.aspx?file_name=/uploadfile/two_dimensional_code_img/ajsmmu/2022/11/20220111.png) 码上扫一扫! |
利妥昔单抗治疗磷脂酶A2受体相关膜性肾病合并系膜增生及新月体形成1例报告 |
柯嘉伟1,任伟夫2,边琪2,孙婧2,梅小斌2,董睿2* |
|
(1. 海军军医大学(第二军医大学)第一附属医院心血管内科, 上海 200433; 2. 海军军医大学(第二军医大学)第一附属医院肾内科, 上海 200433 *通信作者) |
|
摘要: |
|
关键词: 膜性肾病 新月体 肾病综合征 磷脂酶A2受体 利妥昔单抗 |
DOI:10.16781/j.CN31-2187/R.20220111 |
投稿时间:2022-01-29修订日期:2022-06-28 |
基金项目:国家自然科学基金(81300613). |
|
Rituximab in treatment of phospholipase A2 receptor associated membranous nephropathy combined with mesangial hyperplasia and crescentic formation: a case report |
KE Jia-wei1,REN Wei-fu2,BIAN Qi2,SUN Jing2,MEI Xiao-bin2,DONG Rui2* |
(1. Department of Cardiovasology, The First Affiliated Hospital of Naval Medical University (Second Military Medical University), Shanghai 200433, China; 2. Department of Nephrology, The First Affiliated Hospital of Naval Medical University (Second Military Medical University), Shanghai 200433, China *Corresponding author) |
Abstract: |
|
Key words: membranous nephropathy crescent nephrotic syndrome phospholipase A2 receptor rituximab |